BRD2 and endometriosis: Pabuccu et al.19 reported the amount of gonadotrophin used by the number ofrecombinant follicle-stimulating hormone (FSH) ampoules and no significantdifferences were observed in women with stage I–II endometriosis, resectedendometriomas or active endometriomas.